Search results
André Douillard is known for How It's Made (2001), How It's Made: American Made (2017) and How It's Made: Remix (2008).
- André Douillard
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group. F. Mosele, J. Remon, +19 authors. F. André. Published in Annals of Oncology 28 July 2020. Medicine.
Nov 1, 2020 · Highlights. ESMO recommends the use of tumour multigene NGS in NSCLC, cholangiocarcinoma, prostate and ovarian cancers. It is recommended to test TMB in well- and moderately-differentiated neuroendocrine tumours (NETs), cervical, salivary, thyroid and vulvar cancers.
- F. Mosele, J. Remon, J. Mateo, C. B. Westphalen, Fabrice Barlesi, Martijn Lolkema, N. Normanno, A. S...
- 2020
Andre, F. (2020). Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Annals of Oncology, 31 (11), 1491-1505. https://doi.org/10.1016/j.annonc.2020.07.014.
- Annals of Oncology
- English
- 15
- 1491-1505
Jun 10, 2022 · Although next-generation sequencing (NGS) gene panels are accessible to clinicians, there is no consensus on the optimal approach to testing. This study investigates the clinical application of NGS results in the management of advanced thyroid cancer.
The European Society for Medical Oncology (ESMO) is proposing three levels of recommendations for the use of NGS. Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lung cancer (NSCLC), prostate cancers, ovarian cancers and cholangiocarcinoma.
Jun 30, 2005 · Andre, T, Colin, P, Louvet, C, et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer ...
